MRNA
Moderna, Inc.
78.67
1 x 75.69
6 x 83.96
bid
ask
+
6.17
8.52%
10:19 AM
timesize
| Ytd | 166.79% | |
| 1y | 159.82% |
73.68
day range
81.38
22.36
52 week range
78.75
| Open | 73.89 | Prev Close | 72.50 | Low | 73.68 | High | 81.38 | Mkt Cap | 31.28B |
| Vol | 4.16M | Avg Vol | 7.41M | EPS | -8.14 | P/E | N/A | Forward P/E | -17.52 |
| Beta | 1.03 | Short Ratio | 10.94 | Inst. Own | 78.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-31 | 50-d Avg | 52.14 | 200-d Avg | 40.84 | 1yr Est | 44.25 |
| Income Statement | |||
| Total Revenue | 389.00M | ||
| Revenues (USD) | 389.00M | ||
| Cost of Revenue | 955.00M | ||
| Gross Profit | -566.00M | ||
| Operating Expenses | 822.00M | ||
| Research and Development Expense | 649.00M | ||
| Selling, General and Administrative Expense | 173.00M | ||
| Operating Income | -1.39B | ||
| Income Tax Expense | 9.00M | ||
| Net Income | -1.34B | ||
| Net Income Common Stock | -1.34B | ||
| Net Income Common Stock (USD) | -1.34B | ||
| Consolidated Income | -1.34B | ||
| Earnings per Basic Share | -3.40 | ||
| Earnings per Basic Share (USD) | -3.40 | ||
| Earnings per Diluted Share | -3.40 | ||
| Earning Before Interest & Taxes (EBIT) | -1.33B | ||
| Earning Before Interest & Taxes (USD) | -1.33B | ||
| Weighted Average Shares | 395.00M | ||
| Weighted Average Shares Diluted | 395.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.91B | ||
| Cash and Equivalents (USD) | 1.91B | ||
| Investments | 5.55B | ||
| Investments Current | 3.30B | ||
| Investments Non-Current | 2.25B | ||
| Trade and Non-Trade Receivables | 71.00M | ||
| Current Assets | 5.77B | ||
| Property, Plant & Equipment Net | 2.79B | ||
| Total Assets | 11.49B | ||
| Total Debt | 1.25B | ||
| Current Liabilities | 2.40B | ||
| Debt Non-Current | 1.25B | ||
| Total Liabilities | 4.08B | ||
| Accumulated Retained Earnings (Deficit) | 5.88B | ||
| Accumulated Other Comprehensive Income | 25.00M | ||
| Shareholders Equity | 7.41B | ||
| Shareholders Equity (USD) | 7.41B | ||
| Assets Non-Current | 5.72B | ||
| Total Debt (USD) | 1.25B | ||
| Deferred Revenue | 256.00M | ||
| Inventory | 146.00M | ||
| Liabilities Non-Current | 1.69B | ||
| Trade and Non-Trade Payables | 161.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 59.00M | ||
| Net Cash Flow from Financing | 17.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -688.00M | ||
| Capital Expenditure | -62.00M | ||
| Issuance (Purchase) of Equity Shares | 19.00M | ||
| Net Cash Flow from Investing | -76.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -14.00M | ||
| Net Cash Flow from Operations | -630.00M | ||
| Effect of Exchange Rate Changes on Cash | 1000.00K | ||
| Share Based Compensation | 104.00M | ||